We are live on ! Find out more
Exane Derivatives

Exane Derivatives Portfolio holdings

AUM $174M Turnover 34.02%
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+3.21%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$507M
AUM Growth
-$160M
Cap. Flow
-$110M
Cap. Flow %
-21.64%
Top 10 Hldgs %
40.1%
Holding
696
New
71
Increased
159
Reduced
213
Closed
50
Avg Time Held Equity + Options
1.1 years
Top 10 Avg Time Held Equity + Options
0.3 years
Top 20 Avg Time Held Equity + Options
0.2 years
Avg Time Held Equity only
1.2 years
Top 10 Avg Time Held Equity only
0.3 years
Top 20 Avg Time Held Equity only
0.2 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 41.06%
2 Financials 12.36%
3 Technology 8.29%
4 Consumer Staples 6.89%
5 Consumer Discretionary 6.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
DB icon
1
Deutsche Bank
DB
$67.8B
$33.5M 6.61%
2,063,487
+843,180
+69% +$11.9M
2014 Q4
8 quarters
EEM icon
2
iShares MSCI Emerging Markets ETF
EEM
$28.3B
$31.1M 6.14%
888,524
+329,934
+59% +$11.9M
2015 Q1
7 quarters
DB icon
3
PUT
Deutsche Bank
DB
$67.8B
$26.8M 5.29%
90,065
-46,689
-34% -$658K
2016 Q3
1 quarter
FXI icon
4
iShares China Large-Cap ETF
FXI
$3.97B
$24.1M 4.75%
693,424
+282,421
+69% +$10.4M
2014 Q4
8 quarters
USO icon
5
United States Oil Fund
USO
$1.82B
$20.6M 4.07%
219,745
-59,493
-21% -$5.25M
2014 Q4
8 quarters
DB icon
6
CALL
Deutsche Bank
DB
$67.8B
$20.5M 4.05%
74,358
+757
+1% +$10.7K
2016 Q3
1 quarter
RSX
7
DELISTED
VanEck Russia ETF
RSX
$15.9M 3.14%
749,846
+498,662
+199% +$9.7M
2014 Q4
8 quarters
UBS icon
8
UBS Group
UBS
$148B
$12.7M 2.51%
813,750
-320,204
-28% -$4.82M
2016 Q2
2 quarters
BUD icon
9
AB InBev
BUD
$168B
$11.3M 2.23%
107,101
+81,529
+319% +$9.14M
2015 Q3
5 quarters
CTLT icon
10
DELISTED
CATALENT, INC.
CTLT
$6.65M 1.31%
246,886
+75,762
+44% +$1.88M
2016 Q2
2 quarters
CL icon
11
Colgate-Palmolive
CL
$77.9B
$5.8M 1.15%
88,708
-23,752
-21% -$1.63M
2015 Q1
7 quarters
ILMN icon
12
Illumina
ILMN
$33.4B
$5.57M 1.1%
44,745
+44,744
+4,474,400% +$6.03M
2015 Q1
7 quarters
UBS icon
13
CALL
UBS Group
UBS
$148B
$5.49M 1.08%
34,103
+3,500
+11% +$52.7K
2016 Q3
1 quarter
GOOGL icon
14
Alphabet (Google) Class A
GOOGL
$3.54T
$4.95M 0.98%
124,980
+104,180
+501% +$4.17M
2015 Q4
4 quarters
BX icon
15
Blackstone
BX
$99.2B
$4.95M 0.98%
183,051
+37,986
+26% +$986K
2015 Q1
7 quarters
USO icon
16
PUT
United States Oil Fund
USO
$1.82B
$4.9M 0.97%
2,468
-1,804
-42% -$159K
2016 Q3
1 quarter
META icon
17
Meta Platforms (Facebook)
META
$1.64T
$4.34M 0.86%
37,687
-29,572
-44% -$3.63M
2015 Q2
6 quarters
UBS icon
18
PUT
UBS Group
UBS
$148B
$4.32M 0.85%
44,003
-22,037
-33% -$332K
2016 Q3
1 quarter
STZ icon
19
Constellation Brands
STZ
$24.6B
$4.31M 0.85%
28,147
+27,285
+3,165% +$4.33M
2014 Q4
8 quarters
AVGO icon
20
Broadcom
AVGO
$1.53T
$4.26M 0.84%
241,050
-239,820
-50% -$4.15M
2015 Q1
7 quarters
AZN icon
21
AstraZeneca
AZN
$294B
$4.24M 0.84%
77,573
-45,065
-37% -$2.56M
2016 Q3
1 quarter
DVN icon
22
Devon Energy
DVN
$46.6B
$4.19M 0.83%
91,811
+8,741
+11% +$386K
2015 Q4
4 quarters
STLA icon
23
CALL
Stellantis
STLA
$12.8B
$4.19M 0.83%
4,157
-4,524
-52% -$33.8K
2016 Q3
1 quarter
BCR
24
DELISTED
CR Bard Inc.
BCR
$4.18M 0.83%
18,629
-18,016
-49% -$3.91M
2016 Q2
2 quarters
AMAT icon
25
Applied Materials
AMAT
$294B
$4.18M 0.82%
129,431
-147,203
-53% -$4.48M
2016 Q1
3 quarters

Similar funds

Exane Derivatives's Q4 2016 Portfolio in Review

As of Q4 2016, Exane Derivatives held 696 positions worth $507M, down 24% from $666M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Exane Derivatives withdrew a net $110M in Q4 2016, closing 50 positions and reducing 213 holdings. Its most notable exit was Vale, an estimated $8.59M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, up from 40% a quarter earlier, followed by Financials and Technology.

Against the trend, Exane Derivatives opened a new position in Ingredion worth $4.09M.

  • Exane Derivatives's largest Q4 2016 buy was Ingredion: 32,719 shares worth $4.09M.
  • Exane Derivatives added most to iShares MSCI Emerging Markets ETF in Q4 2016, an estimated $11.9M increase.
  • Exane Derivatives's biggest Q4 2016 reduction was iShares MSCI Thailand ETF, cutting an estimated $12.4M.
  • Exane Derivatives fully exited Vale in Q4 2016, selling an estimated $8.59M.
  • Exane Derivatives's ten largest holdings make up 40% of its $507M portfolio in Q4 2016.
  • Exane Derivatives opened 71 new positions and closed 50 in Q4 2016.
  • Exane Derivatives's portfolio value fell 24% quarter-over-quarter to $507M.

Based on Exane Derivatives's 13F filing for Q4 2016, filed 27 Jan 2017.